These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3768069)

  • 21. Quantification of ischemic stress during repeated coronary artery occlusion in the dog. A method for validation of therapeutic effects. II. Reproducibility of the release and uptake of electrolytes and substrates.
    Korb H; Hoeft A; Baller D; Wolpers HG; Hellige G; Bretschneider HJ
    Basic Res Cardiol; 1984; 79(1):38-48. PubMed ID: 6732719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
    Farber NE; Pieper GM; Gross GJ
    Circulation; 1988 Aug; 78(2):450-61. PubMed ID: 3396181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of mivazerol on myocardial lactate production, blood flow and electrocardiographic signs of ischaemia induced by coronary artery ligation in the anaesthetised dog.
    Riemersma RA; Debeer LJ
    Arzneimittelforschung; 1997 Jan; 47(1):10-3. PubMed ID: 9037436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of ischemic stress during repeated coronary artery occlusion in the dog. A method for validation of therapeutic effects. I. Estimation of O2-debt and O2-repayment.
    Hoeft A; Korb H; Baller D; Wolpers HG; Hellige G; Bretschneider HJ
    Basic Res Cardiol; 1984; 79(1):27-37. PubMed ID: 6732718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion.
    O'Connor KM; Friehling TD; Kelliher GJ; MacNab MW; Wetstein L; Kowey PR
    Am Heart J; 1986 Apr; 111(4):683-8. PubMed ID: 3953390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium.
    Lefer AM; Mentley R; Sun JZ
    Circ Res; 1988 Sep; 63(3):621-7. PubMed ID: 3136950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective thromboxane synthetase inhibitors. 2. 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogues.
    Cross PE; Dickinson RP; Parry MJ; Randall MJ
    J Med Chem; 1986 Mar; 29(3):342-6. PubMed ID: 3081722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboxane synthetase inhibitors and antihypertensive agents. 2. N-[(1H-imidazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones and N-[(1H-1,2,4-triazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones as unique antihypertensive agents.
    Press JB; Wright WB; Chan PS; Marsico JW; Haug MF; Tauber J; Tomcufcik AS
    J Med Chem; 1986 May; 29(5):816-9. PubMed ID: 3517332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1985; 7(2):327-34. PubMed ID: 2581088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of a polypeptide drug on the state of energy metabolism of myocardial cells in hypoxic and ischemic conditions].
    Pavlenko VS; Ershov VI; Andreeva LI; Kazantseva ST; Khavinson VKh
    Biull Eksp Biol Med; 1991 Jul; 112(7):24-7. PubMed ID: 1793841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective thromboxane synthetase inhibitors. 3. 1H-imidazol-1-yl-substituted benzo[b]furan-, benzo[b]thiophene-, and indole-2- and -3-carboxylic acids.
    Cross PE; Dickinson RP; Parry MJ; Randall MJ
    J Med Chem; 1986 Sep; 29(9):1637-43. PubMed ID: 3746813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboxane synthetase inhibitors and antihypertensive agents. 1. N-[(1H-imidazol-1-yl)alkyl]aryl amides and N-[(1H-1,2,4-triazol-1-yl)alkyl]aryl amides.
    Wright WB; Press JB; Chan PS; Marsico JW; Haug MF; Lucas J; Tauber J; Tomcufcik AS
    J Med Chem; 1986 Apr; 29(4):523-30. PubMed ID: 3959030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of production of thromboxane A2 by the sheep heart following coronary occlusion.
    Carter J; Reynoldson JA; Harper CM; Heywood LH; Thorburn GD
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 83(2):387-92. PubMed ID: 2872003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxygen metabolism and oxygen debt repayment after myocardial ischemia.
    COFFMAN JD; GREGG DE
    Am J Physiol; 1961 Nov; 201():881-7. PubMed ID: 13880164
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of 3-(1-Methyl-1
    Hattan CM; Shojaie J; Lau SS; Anders MW
    Synth Commun; 2013 Jan; 43(1):1-8. PubMed ID: 24882887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of thromboxane synthetase by the imidazole derivative 3-(1H-imidazol-1-yl-methyl)-2-methyl-1H-indole-1-propanoic acid as a novel therapeutic approach to experimental myocardial ischemia.
    Korb H; Hoeft A; Wober W; Wolpers HG; Hellige G
    Arzneimittelforschung; 1986 Jul; 36(7):1040-4. PubMed ID: 3768069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interference with the prostaglandin system as a therapeutical concept to protect the myocardium during ischemic stress: experimental studies with inhibition of thromboxane synthesis.
    Korb H; Hoeft A; Borowski A; de Vivie ER; Hellige G
    Thorac Cardiovasc Surg; 1988 Aug; 36(4):187-93. PubMed ID: 3187978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preservation of myocardium in transient ischemia by the thromboxane synthetase inhibitor UK 38.485.
    Hoeft A; Korb H; Böck J; Wolpers HG; Wober W; Hellige G
    Res Exp Med (Berl); 1986; 186(1):35-46. PubMed ID: 3961276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of the metabolic and energetic situation of ischemically stressed myocardium by verapamil after experimental coronary artery occlusion.
    Korb H; Hoeft A; Baller D; Schräder R; Wolpers HG; Hellige G
    Arzneimittelforschung; 1983; 33(11):1546-51. PubMed ID: 6686450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of dichloroacetate in the ischemic heart. Analysis of hemodynamics, myocardial energy metabolism and myocardial pH].
    Mizushima M
    Hokkaido Igaku Zasshi; 1990 May; 65(3):298-310. PubMed ID: 2379912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.